UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Sigma Planning Corp

Sigma Planning Corp decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 14,591 shares of the healthcare conglomerate’s stock after selling 481 shares during the period. Sigma Planning Corp’s holdings in UnitedHealth Group were worth $7,381,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $37,000. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $55,000. Legacy Investment Solutions LLC purchased a new position in UnitedHealth Group during the 3rd quarter worth approximately $57,000. Finally, DecisionPoint Financial LLC grew its stake in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $465.58 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The stock has a fifty day moving average of $519.27 and a two-hundred day moving average of $560.54. The company has a market capitalization of $428.46 billion, a price-to-earnings ratio of 30.04, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.83 earnings per share. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Stephens increased their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Oppenheimer increased their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Wells Fargo & Company reduced their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.